Characteristics of studies fulfilling inclusion criteria in the meta-analysis.
收藏数据链接：
官方服务：
资源简介：
D: dexamethasone; L: lenalidomide; MM: multiple myeloma; P: placebo; MPR (melphalan-prednisone-lenalidomide): nine 28-d cycles of melphalan (at a dose of 0.18 mg/kg of body weight on day 1–4), prednisone (2 mg/kg on day 1–4), and lenalidomide (10 mg on days 1–21).
创建时间：
2015-12-02
